A novel protease obtained from FBS-containing culture supernatant, that processes single chain form hepatocyte growth factor to two chain form in serum-free culture.
about
Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitorHepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironmentMet receptor tyrosine kinase: enhanced signaling through adapter proteinsDistribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues. Cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissuesGenomic structure and chromosomal localization of the human hepatocyte growth factor activator inhibitor type 1 and 2 genesImmunohistochemical localization of hepatocyte growth factor activator (HGFA) in developing mouse liver tissues. Heterogeneous distribution of HGFA proteinIntegrating EMR-linked and in vivo functional genetic data to identify new genotype-phenotype associationsHepatocyte growth factor system in the mouse uterus: variation across the estrous cycle and regulation by 17-beta-estradiol and progesterone.Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator.Emerging multifunctional aspects of cellular serine proteinase inhibitors in tumor progression and tissue regeneration.Roles of hepatocyte growth factor activator (HGFA) and its inhibitor HAI-1 in the regeneration of injured gastrointestinal mucosa.The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis.Proteomic analysis of white and yellow seminal plasma in turkeys (Meleagris gallopavo).The molecular and clinical impact of hepatocyte growth factor, its receptor, activators, and inhibitors in wound healing.Targeting the Met signaling pathway in renal cancer.Hepatocyte growth factor activator (HGFA): pathophysiological functions in vivo.TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases.Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo.Upregulation of HGF activator inhibitor type 1 but not type 2 along with regeneration of intestinal mucosa.Myogenic cell response to muscle contraction with short electrical stimulation.Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro.Inhibitors of HGFA, Matriptase, and Hepsin Serine Proteases: A Nonkinase Strategy to Block Cell Signaling in Cancer.Hepatocyte growth factor--a new marker for prognosis in acute coronary syndrome.Hepatocyte growth factor activator inhibitor type 1 inhibits protease activity and proteolytic activation of human airway trypsin-like protease.Mammary fibroblast-derived hepatocyte growth factor stimulates growth and morphogenesis of mouse mammary tumor cells in primary culture.
P2860
Q24322087-1B65BF2C-3996-4378-A4C9-6CE607923709Q28140022-2D430934-FF83-44C0-BAA8-286AF04385A7Q28140219-5423B274-B62B-4BE9-884C-735B4E74293CQ28142489-94C70EF8-C02A-4E39-A4A0-60A960AB90EFQ28145050-180F28F9-B937-4AB4-B5C9-451F433B1C62Q28592355-ACA62D60-23B4-4BD7-A522-56FF251920A3Q30000676-3001478F-1736-4068-9ADE-0481AFB6D85FQ33868809-749CDA20-91A2-4277-908E-E7686044F1FCQ34379859-03A645A9-F34C-4A55-85C4-62E3A1B9AD88Q34592412-2F79E139-B939-4B68-B20C-2FC085606114Q35062087-49572274-F32D-4EB9-8602-BA5DD23BB0C0Q35224818-4255177D-19F6-48D1-BFA3-FD3CF1E1719EQ35675760-DF14B1F7-0236-4532-9F94-302FC2B840D7Q36395707-C75EF8A1-B766-4B32-83FE-DB2ED88C5900Q37331862-1E4BF21F-2166-4D1F-8837-705ADE7A4E2EQ37733681-D2A0CF90-2D5C-4C0F-B358-5693EA9F6336Q38339809-A624ECEA-6503-44B0-946A-FE3984ABE6D8Q40020532-BF7803E5-8FC7-49E2-8ACB-5AAFA0370CCFQ40384156-732459B8-16A6-4500-8223-7C52DCB7D3AAQ40887379-BB994758-0BA3-4121-9E6A-5B369236CE3CQ42541660-857600A2-9370-43AF-8C68-04697B75D4E5Q42803690-451DEB67-FDE3-4460-8841-A7CD6FCD028CQ42837140-C812CB26-5DF3-4F3E-A61F-E0A3C2A7F608Q44822548-CE3214E7-4A69-47A7-861B-3893FA2AF5A7Q51764334-A8F6DB67-00EB-4DC1-A50C-B546783EEA3CQ55003815-CF84782B-4A97-4027-BDBA-908309992256
P2860
A novel protease obtained from FBS-containing culture supernatant, that processes single chain form hepatocyte growth factor to two chain form in serum-free culture.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
A novel protease obtained from ...... in form in serum-free culture.
@ast
A novel protease obtained from ...... in form in serum-free culture.
@en
A novel protease obtained from ...... in form in serum-free culture.
@nl
type
label
A novel protease obtained from ...... in form in serum-free culture.
@ast
A novel protease obtained from ...... in form in serum-free culture.
@en
A novel protease obtained from ...... in form in serum-free culture.
@nl
prefLabel
A novel protease obtained from ...... in form in serum-free culture.
@ast
A novel protease obtained from ...... in form in serum-free culture.
@en
A novel protease obtained from ...... in form in serum-free culture.
@nl
P2093
P356
P1433
P1476
A novel protease obtained from ...... in form in serum-free culture.
@en
P2093
P2888
P304
P356
10.1007/BF02522039
P577
1992-01-01T00:00:00Z
P6179
1010373410